Vivos Inc logo

Vivos Inc

$ 0.05 -0.00275 (-5.56%) 03:57 PM EST
P/E:
At Loss
P/B:
15.59
Market Cap:
$ 16.78M
Enterprise V:
$ 16.08M
Volume:
407.84K
Avg Vol (2M):
614.48K
Volume:
407.84K
Market Cap $:
16.78M
PE Ratio:
At Loss
Avg Vol (2-Month):
614.48K
Enterprise Value $:
16.08M
PB Ratio:
15.59
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Vivos Inc is a radiation oncology medical device company. It is engaged in the development of RadioGel which is a brachytherapy device comprising highly insoluble particles delivered by needle injection using a water-polymer composite for high-dose treatment of non-resectable solid tumors. IsoPet is another product of the company used for the treatment of solid tumors in animals. The company derives revenue through sales of its products.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.81
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -54.22
Distress
Grey
Safe
Beneish M-Score -1836.21
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 40
3-Year EPS without NRI Growth Rate 58.5
3-Year FCF Growth Rate 38.7

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 46.09
9-Day RSI 46.23
14-Day RSI 44.72
6-1 Month Momentum % -28.14
12-1 Month Momentum % -58.77

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.15
Quick Ratio 5.15
Cash Ratio 4.89
Days Sales Outstanding 90.47
Days Payable 11796.8

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -28.1

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 84.62
Operating Margin % -4994.87
Net Margin % -4787.18
ROE % -140.76
ROA % -112.11
ROIC % -660.34
ROC (Joel Greenblatt) % -99999999.99
ROCE % -139.83
Years of Profitability over Past 10-Year 1

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio 15.59
EV-to-EBIT -8.13
EV-to-EBITDA -8.13
EV-to-Revenue 387.13
EV-to-FCF -16.61
Earnings Yield (Greenblatt) % -12.29

Financials

RDGL's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:RDGL

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.039
EPS (TTM) ($) -0.005
Beta 1.59
Volatility % 45.48
14-Day RSI 44.72
14-Day ATR ($) 0.004697
20-Day SMA ($) 0.050141
12-1 Month Momentum % -58.77
52-Week Range ($) 0.0405 - 0.127
Shares Outstanding (Mil) 358.91

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Vivos Inc Filings

Document Form Filing Date
No Filing Data

Vivos Inc Analysis

Share your research

Headlines

See More
No news.